Diabetes and the enteric nervous system
- 17 October 2007
- journal article
- review article
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 19 (12), 951-960
- https://doi.org/10.1111/j.1365-2982.2007.01023.x
Abstract
Diabetes is associated with several changes in gastrointestinal (GI) motility and associated symptoms such as nausea, bloating, abdominal pain, diarrhoea and constipation. The pathogenesis of altered GI functions in diabetes is multifactorial and the role of the enteric nervous system (ENS) in this respect has gained significant importance. In this review, we summarize the research carried out on diabetes‐related changes in the ENS. Changes in the inhibitory and excitatory enteric neurons are described highlighting the role of loss of inhibitory neurons in early diabetic enteric neuropathy. The functional consequences of these neuronal changes result in altered gastric emptying, diarrhoea or constipation. Diabetes can also affect GI motility through changes in intestinal smooth muscle or alterations in extrinsic neuronal control. Hyperglycaemia and oxidative stress play an important role in the pathophysiology of these ENS changes. Antioxidants to prevent or treat diabetic GI motility problems have therapeutic potential. Recent research on the nerve–immune interactions demonstrates inflammation‐associated neurodegeneration which can lead to motility related problems in diabetes.Keywords
This publication has 77 references indexed in Scilit:
- Abnormal Ghrelin and Pancreatic Polypeptide Responses in GastroparesisDigestive Diseases and Sciences, 2006
- Altered expression of neuronal nitric oxide synthase in the duodenum longitudinal muscle–myenteric plexus of obesity induced diabetes mouse: Implications on enteric neurodegenerationBiochemical and Biophysical Research Communications, 2005
- VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblastsRheumatology, 2005
- Morphoquantitative Aspects of NADH‐Diaphorase Myenteric Neurons in the Ileum of Diabetic Rats Treated with Acetyl‐l‐CarnitineAnatomia, Histologia, Embryologia, 2005
- Insulin Regulates Neuronal M2Muscarinic Receptor Function in the Ileum of Diabetic RatsThe Journal of pharmacology and experimental therapeutics, 2003
- Pathophysiological significance of neuronal nitric oxide synthase in the gastrointestinal tractThe Esophagus, 2003
- Failure of the nitric oxide synthase inhibitor to stimulate duodenal bicarbonate secretion in streptozotocin-diabetic ratsLife Sciences, 1997
- Enteric neuropeptides in streptozotocin-diabetic rats; effects of insulin and aldose reductase inhibitionJournal of the Autonomic Nervous System, 1996
- Effect of streptozotocin-induced diabetes mellitus on release of vasoactive intestinal polypeptide from rodent small intestineDigestive Diseases and Sciences, 1995
- Effects of chronic experimental streptozotocin-induced diabetes on the noradrenergic and peptidergic innervation of the rat alimentary tractBrain Research, 1988